OCR tells senators cultivation could start within weeks, and that it cannot authorize sales until a testing lab opens

As of August 8, 2026. The Office of Cannabis Regulation told the Legislature on August 7 that licensed cannabis cultivation could begin in the territory within weeks, and that one or two dispensaries could open before the end of the year. The written testimony the office filed the same day says commercial sales cannot be authorized until a cannabis testing laboratory is operating, and that the selected laboratory still does not have a facility.

The two statements do not conflict. Cultivation is not retail. But they set the order of operations for anyone waiting on a legal purchase in the Virgin Islands, and the lab is the gate.

What the testimony says about the lab

OCR appeared before the Committee on Budget, Appropriations and Finance, chaired by Senator Novelle E. Francis Jr., to present its Fiscal Year 2027 budget request, covered separately in OCR’s $1.61 million budget request. The office was one of four items on the August 7 agenda, alongside the Department of Agriculture, the Department of Licensing and Consumer Affairs, and the Virgin Islands Food and Farm Council.

On laboratory capacity, the testimony reads:

While a laboratory vendor has been selected, delays associated with securing an appropriate facility have required continued coordination among OCR, the laboratory, and other stakeholders. Until this critical component is operational, the Office cannot responsibly authorize commercial sales.

A testing lab has been under construction on St. Croix since at least March 2026, and the territory’s cannabis testing standards took effect on May 14, 2026. Every product sold in a licensed dispensary has to pass them. The testimony does not name the vendor, give a facility address, or set a target date for the lab to open.

What the office told senators

Executive Director Joanne Moorehead said licensed cultivation could begin “within actually probably a matter of weeks,” and that “a dispensary or two” could open before the end of the year, according to the St. John Source’s account of the hearing. Moorehead cautioned that not every conditionally approved business would be ready to operate in 2026.

By that account, OCR has conditionally approved roughly 15 cultivation licenses, 10 dispensary licenses, 10 manufacturing licenses, two research and development licenses, and nine micro-cultivation permits. Those spoken totals differ from OCR’s own written record, which shows 14 conditional commercial cultivation licenses and 11 micro-cultivation permits. The office has not published a reconciliation.

The manufacturing figure differs from OCR’s paperwork too. The public notice the office posted on August 4 lists eight approved manufacturing applicants and their scores, not ten. That notice is dated July 8.

Moorehead also said licensing fees will not cover the office’s technology costs. Senator Kurt A. Vialet, who raised the question, argued that the cannabis industry should eventually fund its own regulation rather than draw on the General Fund.

A withdrawal that moved the supply chain

The testimony records one setback without naming the business involved: “One example occurred earlier this year when the unexpected withdrawal of a conditionally approved licensee significantly affected anticipated supply-chain development.” OCR says it assessed the effect on the wider market rather than treating the withdrawal as a single licensing matter.

The office also reported its Fiscal Year 2026 workload to the Post Audit Division: 62 license and permit applications reviewed, 90 business inspections, 23 inspections of home growers, 11 investigations, and two joint operations. On the medical and registration side, it listed nine registered practitioners, 144 electronic medical certifications, 67 patient identification cards, one registered sacramental organization, and nine cannabis business agent registrations.

What to watch

The second-round license window closes September 15. Public comment on the draft intoxicating hemp rules is also open, and OCR has not printed a closing date. Whether any cultivator starts a legal crop inside the “matter of weeks” window will put a date on the office’s own estimate. The lab facility decides everything downstream: until it is operating, OCR has said in writing that it will not authorize a commercial sale. Moorehead first put regulated sales in fall 2026 in February.